SBI Lentiviral Technologies

SBI Lentiviral Technologies pGF2 mcmv

NEW PRODUCT ALERT!

SBI is labored as a lot as announce the launch of our subsequent interval of pGreenFire signalling pathway reporters! We’ve upgraded these customary lentivectors with a intelligent design that enables dependable interval of standard cell traces and have furthermore modified the conventional luciferase reporter with crimson firefly luciferase, which opens up the potential of performing a dual-spectral luciferase assay and delivers larger sensitivity for in vivo options than typical luciferase.

Overview

Make your non-public pGreenFire 2.zero reporter vector or use as a detrimental administration

With the pGreenFire 2.zero mCMV Cloning & Unfavorable Administration Lentivector & Virus (pGF2-mCMV-rFluc-T2A-GFP-mPGK-Puro), chances are high you may profit from our sturdy pGreenFire 2.zero lentivector know-how to create your non-public transcriptional response half (TRE) reporter or use pGreenFire 2.zero mCMV as-is as a detrimental administration.

 

SBI Lentiviral Technologies
SBI Lentiviral Applied sciences

With the pGreenFire 2.zero mCMV Cloning & Unfavorable Administration Lentivector, XhoI and NheI internet sites are positioned upstream of a minimal CMV promoter (mCMV) so chances are high you may clone in your non-public TREs. Upon activation, the TREs and mCMV promoter collectively drive co-expression of crimson firefly luciferase and GFP so chances are high you may quantitatively measure transcriptional prepare utilizing each fluorescence and luciferase prepare.

What makes our next-gen pGreenFire 2.zero vectors even bigger than completely totally different TRE reporter vectors is the good design, which gives in a constitutive various cassette for normal cell line interval whereas minimizing interference with the upstream TRE. By utilizing a weak/low-cost mPGK promoter to drive the antibiotic various marker (puromycin resistance) and fully arranging the conditional reporter genes, the choice marker is reliably expressed with out compromising conditional expression of rFLuc and GFP.

GreenFire Fundamentals

For a lot of who’re not acquainted with our pGreenFire reporters, each 1.zero and some.zero share an similar core effectivity—transcriptional response parts (TREs) are positioned upstream of a minimal CMV promoter (mCMV) and the pGreenFire luciferase-T2A-GFP co-expression cassette. All through the absence of transcriptional activation, the mCMV promoter has negligible prepare  leading to little- to no- luciferase prepare or GFP fluorescence (Resolve 1). Nonetheless, upon activation of the TREs, akin to in response to the addition of an inducer, the TREs plus the mCMV promoter drive expression of each luciferase and GFP in a dose-dependent sample (Resolve 1). The result’s the pliability to quantitatively measure pathway activation utilizing luciferase prepare or whereas imaging utilizing GFP.

As with all of our pGreenFire 2.zero lentivectors, the GreenFire cassette now consists of crimson firefly luciferase (rFLuc), a T2A co-expression half, and GFP. The swap to rFLuc opens up the potential of performing a dual-spectral luciferase assay and likewise delivers larger sensitivity for in vivo options than typical luciferase.

 

 

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 100 ug
EUR 525.6

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.08ML 0.08 ml
EUR 165

ARHGDIA Antibody / RHOGDI Antibody

F54788-0.4ML 0.4 ml
EUR 379

Antibody

A1360-500 each Ask for price

Anti-Glycolipid Antibody (AGA) Antibody

20-abx004855
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx008109
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx123734
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx014333
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Ly1 Antibody Reactive (LYAR) Antibody

abx033330-400ul 400 ul
EUR 627.6

Ly1 Antibody Reactive (LYAR) Antibody

abx033330-80l 80 µl
EUR 343.2

Anti-Glycolipid Antibody (AGA) Antibody

abx036399-100ug 100 ug
EUR 469.2

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319900
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319901
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319905
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319913
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycolipid Antibody (AGA) Antibody

abx230204-100ug 100 ug
EUR 577.2

Ly1 Antibody Reactive (LYAR) Antibody

20-abx324434
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Leave a Comment

Your email address will not be published.